Its listing rules, approved by the SEC in late 2025, emphasize issuer friendliness without relaxing quantitative standards. Companies may request confidential pre-application eligibility reviews at no cost, an innovation that can save months of uncertainty and advisory fees. The exchange also plans lower recurring costs and streamlined compliance obligations, designed to appeal especially to midsize and emerging-growth firms that find New York’s red tape prohibitive. For issuers, the advantages are procedural rather than ideological: less bureaucracy, clearer guidance, and faster time to market — all within the same legal protections that govern other national exchanges.